Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_2
1
25%
Ph phase_3
1
25%
Ph early_phase_1
1
25%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Terminated(1)
Other(3)

Detailed Status

unknown3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)
N/A1 (25.0%)

Trials by Status

terminated125%
unknown375%

Recent Activity

0 active trials
Showing 4 of 4
unknownphase_3

Balloon-occluded Retrograde Transvenous Obliteration for Gastric Variceal Rebleeding

NCT06106971
unknownphase_2

Treatment of Epidermoid Cysts

NCT05597995
unknownearly_phase_1

is Ultrasound-guided Foam Sclerotherapy a Cost-effective Alternate for Treatment of Varicose Veins?

NCT04655417
terminatednot_applicable

Perforator Vein Injection for Symptomatic Venous Disease

NCT03363633

Clinical Trials (4)

Showing 4 of 4 trials
NCT06106971Phase 3

Balloon-occluded Retrograde Transvenous Obliteration for Gastric Variceal Rebleeding

Unknown
NCT05597995Phase 2

Treatment of Epidermoid Cysts

Unknown
NCT04655417Early Phase 1

is Ultrasound-guided Foam Sclerotherapy a Cost-effective Alternate for Treatment of Varicose Veins?

Unknown
NCT03363633Not Applicable

Perforator Vein Injection for Symptomatic Venous Disease

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4